Wadden TA, Bailey TS, Billings LK, Davies M, Frias JP, Koroleva A, et al
Theyre not wrong, but heres the thing: The alternatives either disappeared or became unaffordable overnight
These therapies can be cost-prohibitive and may require multiple sessions, limiting accessibility for a broader patient population
collapse Signs of sepsis: high fever or very low temperature, rapid breathing, confusion, or feeling extremely unwell following an injection Severe hypoglycaemia with loss of consciousness or inability to swallow Severe chest pain or significant difficulty breathing Contact your GP or a healthcare professional promptly if you experience: Injection site reactions such as persistent redness, swelling, warmth, or pain, which may indicate infection or an inflammatory response Systemic symptoms including fever, chills, or malaise following administration Gastrointestinal symptoms such as severe or persistent nausea, vomiting, or abdominal pain these are known effects associated with GLP-1 receptor agonism and may require clinical assessment [15] [6] Symptoms of hypoglycaemia shakiness, sweating, confusion, or palpitations particularly if retatrutide is being used alongside other glucose-lowering agents Cardiovascular symptoms such as a rapid or irregular heartbeat Report suspected side effects via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk
Fever accompanying constipation : Could indicate infection or inflammatory process
Does my insurance cover the recommended medication, and are there more affordable alternatives if coverage is an issue
